priligy united states Methods Patients with progression or prior exposure to tamoxifen with or without gonadotropin releasing hormone agonists, either sequentially or concurrently, in adjuvant or metastatic setting were randomly assigned 2 1 to the EVE arm leuprorelin LET EVE or the LET arm leuprorelin LET until disease progression or unacceptable toxicity
priligy united states Methods Patients with progression or prior exposure to tamoxifen with or without gonadotropin releasing hormone agonists, either sequentially or concurrently, in adjuvant or metastatic setting were randomly assigned 2 1 to the EVE arm leuprorelin LET EVE or the LET arm leuprorelin LET until disease progression or unacceptable toxicity